NCT00027027View on ClinicalTrials.gov

Safety Study of rhuMAb 2C4 to Treat Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

August 31, 2003

Study Completion Date

August 31, 2003

Conditions

Neoplasms

Interventions

DRUG

rhuMAb 2C4

Trial Locations (1)

90211

Cedars-Sinai Medical Center, Los Angeles

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

lead

Genentech, Inc.

INDUSTRY